Cargando…
PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431585/ http://dx.doi.org/10.1097/01.HS9.0000851092.94445.bd |
| _version_ | 1784780095309742080 |
|---|---|
| author | Novosad, O. Pastushenko, I. Kadnikova, T. Tytorenko, I. Martynchyk, A. Gorbach, O. Ashyhmin, A. Kmetyuk, Y. Karpova, O. Mykhalska, L. Kindrakevych, O. Novikov, M. Oliinichenko, O. Kriachok, I. |
| author_facet | Novosad, O. Pastushenko, I. Kadnikova, T. Tytorenko, I. Martynchyk, A. Gorbach, O. Ashyhmin, A. Kmetyuk, Y. Karpova, O. Mykhalska, L. Kindrakevych, O. Novikov, M. Oliinichenko, O. Kriachok, I. |
| author_sort | Novosad, O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431585 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94315852022-08-31 PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA Novosad, O. Pastushenko, I. Kadnikova, T. Tytorenko, I. Martynchyk, A. Gorbach, O. Ashyhmin, A. Kmetyuk, Y. Karpova, O. Mykhalska, L. Kindrakevych, O. Novikov, M. Oliinichenko, O. Kriachok, I. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431585/ http://dx.doi.org/10.1097/01.HS9.0000851092.94445.bd Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Novosad, O. Pastushenko, I. Kadnikova, T. Tytorenko, I. Martynchyk, A. Gorbach, O. Ashyhmin, A. Kmetyuk, Y. Karpova, O. Mykhalska, L. Kindrakevych, O. Novikov, M. Oliinichenko, O. Kriachok, I. PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title | PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title_full | PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title_fullStr | PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title_full_unstemmed | PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title_short | PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA |
| title_sort | pb2065: importance of pet as a prognostic marker in treatment strategy choice in patients with hodgkin lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431585/ http://dx.doi.org/10.1097/01.HS9.0000851092.94445.bd |
| work_keys_str_mv | AT novosado pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT pastushenkoi pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT kadnikovat pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT tytorenkoi pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT martynchyka pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT gorbacho pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT ashyhmina pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT kmetyuky pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT karpovao pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT mykhalskal pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT kindrakevycho pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT novikovm pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT oliinichenkoo pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma AT kriachoki pb2065importanceofpetasaprognosticmarkerintreatmentstrategychoiceinpatientswithhodgkinlymphoma |